The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | Surveying clinician practices on MRD utilization for myeloma
Benjamin Derman
• 15 Sep 2019
Benjamin Derman, MD, from the University of Chicago, Chicago, IL, provides insight on an interesting aspect of MRD utilization – surveying clinician practices to give a more in-depth insight. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
